Venturefrom24/7 Wall St.2 days ago5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats UpOncology M&A is accelerating as pharmaceutical companies seek to replenish pipelines and five biotechs emerge as compelling acquisition targets.